A detailed history of United Capital Financial Advisers, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 870 shares of UTHR stock, worth $324,414. This represents 0.0% of its overall portfolio holdings.

Number of Shares
870
Previous 921 5.54%
Holding current value
$324,414
Previous $293,000 6.14%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$311.04 - $363.55 $15,863 - $18,541
-51 Reduced 5.54%
870 $311,000
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $7,076 - $9,890
31 Added 3.48%
921 $293,000
Q1 2024

May 15, 2024

SELL
$210.76 - $249.51 $16,017 - $18,962
-76 Reduced 7.87%
890 $204,000
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $207,574 - $248,204
966 New
966 $212,000
Q2 2023

Aug 14, 2023

SELL
$205.19 - $232.99 $96,849 - $109,971
-472 Reduced 22.98%
1,582 $349,000
Q1 2023

Aug 14, 2023

BUY
$212.99 - $276.17 $100,531 - $130,352
472 Added 29.84%
2,054 $460,000
Q1 2023

May 15, 2023

SELL
$212.99 - $276.17 $543,763 - $705,062
-2,553 Reduced 55.42%
2,054 $460,000
Q4 2022

Feb 14, 2023

BUY
$205.95 - $280.43 $46,750 - $63,657
227 Added 5.18%
4,607 $1.28 Million
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $46,555 - $55,914
-229 Reduced 4.97%
4,380 $917,000
Q2 2022

Aug 11, 2022

BUY
$174.81 - $241.14 $2,796 - $3,858
16 Added 0.35%
4,609 $1.09 Million
Q3 2021

Nov 15, 2021

BUY
$179.86 - $214.88 $359 - $429
2 Added 0.04%
4,593 $848,000
Q2 2021

Aug 13, 2021

SELL
$170.47 - $211.93 $8,523 - $10,596
-50 Reduced 1.08%
4,591 $824,000
Q4 2020

Feb 17, 2021

SELL
$101.87 - $151.79 $101 - $151
-1 Reduced 0.02%
4,641 $704,000
Q3 2020

Nov 13, 2020

BUY
$99.9 - $121.13 $99 - $121
1 Added 0.02%
4,642 $469,000
Q1 2020

May 15, 2020

SELL
$79.39 - $115.35 $60,257 - $87,550
-759 Reduced 14.06%
4,641 $440,000
Q3 2019

Feb 14, 2020

BUY
$74.85 - $85.99 $404,189 - $464,346
5,400 New
5,400 $431,000
Q4 2017

Feb 13, 2018

SELL
$118.58 - $151.28 $911,998 - $1.16 Million
-7,691 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$114.6 - $136.81 $881,388 - $1.05 Million
7,691
7,691 $901,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.